8 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Award for Excellence in Medication-Use Safety
Supported by a grant from the Cardinal Health Foundation
Application Deadline Extended: January 31, 2014
The American Society of Health-System Pharmacists (ASHP) Research and Education Foundation created the Award for Excellence in Medication-Use Safety in 2004. This is the only award program to honor a pharmacist-led multidisciplinary team for its significant institution-wide system improvements relating to medication use.
The $50,000 award, which is sponsored by the Cardinal Health Foundation, recognizes on a national level pharmacy professionals who have assumed a leadership role in promoting safety in the medication-use process. The award also honors two finalists, who each receive $10,000.
2014 Letter of Intent Submission Process
A letter of intent screening component has been added to the Award for Excellence in Medication-Use Safety application process. Applicants are required to submit a letter of intent that describes their medication safety initiative. These letters of intent will be reviewed by external expert reviewers. Based on results of the letters of intent review process, selected applicants will be invited to submit a full application for the award.
Emergency Medicine Foundation Career Development Grant
Deadline for receipt of application : January 10, 2014
The purpose of the Emergency Medicine Foundation (EMF) awards is to support research in emergency medicine. More specifically, the goals of the EMF Career Development Program are 1) to promote research within the specialty of emergency medicine, 2) to advance emergency medical care, and 3) to facilitate the academic growth and development of emergency medicine faculty and thereby invest in the future of the specialty of emergency medicine.
The EMF Career Development Grant Program awards up to $50,000 to be used in any combination of salary support for faculty "release time" and seed money.
GOALS OF THIS RESEARCH AWARD
Emergency medicine research is broadly defined as scientific investigation designed to furnish new knowledge relating to emergency medical care. Such investigations may focus on basic science, clinical applications, preventive medicine, epidemiology, health care policy, or emergency medicine teaching and education.
For this grant cycle, EMF encourages applications with a focus on health services research, including but not limited to, health policy, practice, medical liability, regionalization, patient safety, and hospital utilization. However, it is important to note that EMF welcomes all applications, including research that is not health services-based.
PURPOSE OF THE CAREER DEVELOPMENT GRANT
The EMF Career Development Program was designed to provide the applicant with an opportunity to develop a project from its rudimentary conception into a more sophisticated form that will permit them to apply for extramural funding. The applicant should work in an active, progressive research environment that intimately involves the applicant in the conception, planning, conduct, and reporting of emergency medicine research. At the end of the award period, the applicant should have established long-term research interests and be able to conduct independent research and compete effectively for extramural funding.
QUALIFICATIONS OF THE APPLICANT
Applicants must have and MD, DO, PhD or equivalent degree and hold the rank of instructor or assistant professor in an accredited US medical school and have a primary faculty appointment in an approved emergency medicine residency program.
QUALIFICATIONS AND RESPONSIBILITIES OF THE MENTOR
It is required that the applicant submit a letter of support from a preceptor at the applicant's institution. This letter must describe the mentor’s role and responsibilities. The mentor is responsible for conducting the research projects and supervising the work of the applicant and associate investigators. The mentor must hold an MD, DO, PhD, or equivalent degree. In competitive applications, the mentor will have proven his or her ability to pursue independent research as evidenced by original research publications in peer-reviewed journals and/or funding from extramural sources and evidence of ongoing research activity. The mentor may be in any department but must be within the applicant's institution.
The applicant must demonstrate that access to suitable caseload or patient population will be available for study during the funding period if a clinical research project is proposed. Research involving animals or human subjects must be approved by the institutional review board (IRB), or its equivalent, and a copy of the approval or pending approval sent with this application. IRB approval must be documented prior to dispensation of EMF funds.
EVALUATION OF APPLICATIONS
Each application will be reviewed by emergency medicine specialists who are involved in basic and clinical emergency medicine research. Each application will be judged on the following criteria: 1) the potential to develop the proposed line of investigation into a sustained research career, 2) applicant's background, commitment, and potential as a researcher in emergency medicine, 3) the scientific merit of the research projects, 4) adequacy of funding, and 5) the willingness of the mentor and the institution to train researchers in emergency medicine and provide the necessary facilities and support to complete the projects as described. The final funding decision will be made by the EMF Board of Trustees, and all decisions are final.
TERMS OF THE GRANT
An award of up to $50,000 is provided for one year. Awardees may not apply for a second award.
Emergency Medicine Foundation Research Fellowship Grant
Deadline for receipt of application - January 10, 2014
The Emergency Medicine Foundation awards funds for fellowship stipends to support the development of research expertise in emergency medicine. The goals of the EMF Research Fellowship Program are 1) to promote research within the specialty of emergency medicine, 2) to advance emergency medical care, and 3) to facilitate the academic growth, advanced education, and development of future researchers in emergency medicine and thereby invest in the future of the specialty of emergency medicine.
EMF Research Fellow stipends are available to non-profit institutions that possess the facilities for clinical or basic science research and have on their staff the necessary experienced investigators and educators to promote the academic growth of the research fellow. The Research Fellowship Grant Program awards up to $150,000 over two years. Awards are made with the stipulation that they are to be used only as salary and tuition support for the EMF Research Fellow.
DEFINITION OF EMERGENCY MEDICINE RESEARCH
Emergency medicine research is broadly defined as scientific investigation designed to furnish new knowledge relating to emergency medical care. Such investigations may focus on basic science research, clinical research, preventive medicine, epidemiology, health care policy, or emergency medicine teaching and education.
PURPOSE OF THE FELLOWSHIP
The EMF Research Fellowship is intended to provide the opportunity for formal education in research methodologies, and experience in research in preparation for an academic career as a research scientist. Fellowship proposals pursuing additional degrees (MS, PhD, etc) will receive the highest priority. The fellow should work in an active, progressive research environment that intimately involves the fellow in the conception, planning, conduct, and reporting of emergency medicine research. It is expected that the fellow will receive formal education in such topics as biomedical statistics, research design, laboratory safety, grant writing, and regulatory and ethical concerns. At the end of the Fellowship, the fellow should have a firm foundation in the fundamentals that will prepare the fellow to conduct independent research and compete effectively for extramural funding.
QUALIFICATIONS OF THE FELLOW
The designated research fellow must be a graduate of an ACGME approved emergency medicine residency training program at the beginning of the proposed funding period. The recipient institution must provide the name of the fellow, curriculum vitae and any other pertinent information to EMF prior to start of funding and approval of the fellow is subject to final review by EMF. Strong priority will be given to applicants participating in a degree bearing (MS, PhD, etc) training program during the fellowship.
QUALIFICATIONS AND RESPONSIBILITIES OF THE MENTOR
It is required that the applicant submit a letter of support from a Mentor at the applicant’s institution. This letter must describe the Mentor’s role and responsibilities. The Mentor must hold a MD, DO, PhD or equivalent degree. The Mentor must have proven ability to pursue independent research as evidenced by original research publications in peer-reviewed journals and/or funding from extramural sources. The Mentor may be in any department within the applicant’s institution.
Each application will be reviewed by emergency medicine specialists who are involved/informed in basic and clinical emergency medicine research. Each application will be judged primarily by the likelihood of producing dedicated, qualified researchers in emergency medicine as indicated by 1) the strength of the fellowship educational curriculum (and pursuit of additional degrees; MS, PhD, etc), 2) the qualifications of the Mentor, 3) the scientific merit of the research projects, 4) the adequacy of funding, and 5) the willingness of the Mentor’s institution to train researchers in emergency medicine and provide the necessary facilities and support to complete the curriculum and projects as described. The final funding decision will be made by the Emergency Medicine Foundation Board of Trustees, and all decisions are final.
Duration and Grant Amount
Applicants may apply for up to a total of $150,000 for a two year period.
Patient-Centered Outcomes Research Institute Funding Opportunity: Assessment of Prevention, Diagnosis and Treatment Options
Letter of Intent Deadline: February 1, 2014 at 5:00 pm ET
In this PCORI Funding Announcement (PFA), we seek to fund projects that address critical decisions that face patients, their caregivers, and clinicians every day without adequate information. These decisions must be consequential and be occurring now without key evidence about the comparative effectiveness of two or more options. Patients/caregivers must benefit from new knowledge in ways that are clear and important.
Total Direct Costs: $1.5 Million
Maximum Project Period: 3 Years
Applications may be submitted by:
Any private sector research organization, including any:
Any public sector research organization, including any:
University or college
Hospital or healthcare system
Laboratory or manufacturer
Unit of state or local government
All US applicant organizations must be recognized by the Internal Revenue Service. Foreign organizations and nondomestic components of organizations based in the United States may apply, as long as there is demonstrable benefit to the US healthcare system, and US efforts in the area of patient-centered research can be clearly shown. Organizations may submit multiple applications for funding. Individuals may not apply.
1. Impact of the condition on the health of individuals and populations
2. Potential for the study to improve health care and outcomes
3. Technical merit
5. Patient and stakeholder engagement
*Deadlines are at 5:00 PM ET. If deadlines fall on a weekend or a federal holiday, the deadline will be the following Monday or the next day after the federal holiday.
American Academy of Otolaryngology-Head and Neck Surgery Foundation Resident Research Grant Sponsored by The Doctors Company Foundation
The purpose of this award, which is sponsored by The Doctors Company Foundation, is to stimulate original resident research in otolaryngology that minimizes the occurrence and impact of adverse events and improves patient safety in hospital systems and out-patient settings.
Any resident of an accredited otolaryngology-head and neck surgery training program in the U.S. or Canada is eligible to apply for The Doctors Company Foundation/AAO-HNSF Resident Research Grant. All applicants must be members in good standing of AAO-HNS.
Proposed projects may be related to any area of otolaryngology, but must include a component focused on minimizing the incidence of medical errors within hospital systems and out-patient settings. Proposed projects shall be designed in collaboration with a preceptor investigator and approved by the candidate's department chairperson and institution. The results of the supported investigation must be presented at the closest AAO-HNS Foundation Annual Meeting immediately following the award. The recipient(s) shall be free to publish the results afterwards, but the Foundation shall have the right of first refusal for publication in its journal, Otolaryngology-Head and Neck Surgery. Any presentation or publication of results supported by this award shall acknowledge the contribution of The Doctors Company Foundation/AAO-HNSF Resident Research Grant. Applications must be accompanied by a letter of support from the applicant’s Department Chair verifying that the applicant will be permitted to devote an appropriate amount of time to the conduct and timely completion of the proposed research project. Resident applicants must also work with a faculty member (Preceptor) designated as a co-investigator. A letter of support must also be obtained from the co-investigator (Preceptor). Applicants must obtain letters of support/understanding from all key personnel on the project. Projects which are clinical trials of unproven drugs or devices are outside the areas of Foundation interest for purposes of resident research grants.
1. Amount: $10,000 maximum
2. Period: 12 months, non-renewable
3. Funding: One will be awarded annually from 2012 to 2016
4. Use of Funds: Award funds may be used for any legitimate costs associated with the purpose of the Award, other than salary support for the Principal Investigator. A detailed budget and budget justification constitute part of the application and will be evaluated as an important factor in the review process. If university policy stipulates that a portion of this very modest award must go toward institutional indirect costs, no more than ten percent (10%) of the total costs may be applied for indirect costs. Allowable expenses include consultant fees (e.g., statistician, methodologist); salary support for research assistants or other supporting personnel; computer software or hardware; computer database access fees; and expenses related to presentation or publication of results. Equipment and supplies purchased with this Award become the property of the recipient institution.
5. Notification: Letters of notification will be sent in June of the award year. Please do not call the office prior to this time to inquire about results.
6. Starting Date: The recipient(s) of The Doctors Company Foundation/AAO-HNSF Resident Research Grant will be announced publicly at the closest AAO-HNS Foundation Annual Meeting immediately following the award. The award may be activated as early as July 1 of the year of award, but no later than January 1 of the following year.
Applications are in a similar format to the National Institutes of Health. All applications must be completed and submitted online through ProposalCENTRAL at https://proposalcentral.altum.com.
All applicants must submit a Letter of Intent online no later than midnight Eastern Standard Time December 16, 2013.
Call for Nominations: C.E. Pippenger Award
Presented for Outstanding Contributions to Therapeutic Drug Monitoring
This award is presented in honor of Dr. C.E. Pippenger, International Association of Therapeutic Drug Monitoring and Clinical Toxicology Honorary Member.
Terms of Reference
The Award shall be presented to an individual as a mark of recognition of outstanding contributions to Therapeutic Drug Monitoring. The recipient must be a member in good standing of the Association at the day of the award presentation.
The Award shall usually be presented bi-annually, but if in the opinion of the Awards Committee no suitable candidate is available, the Award shall not be presented.
The Award shall be accompanied by a framed certificate and an honorarium in the amount of USD $1,500.
The recipient of the Award shall be chosen by the Awards Committee and approved by the IATDMCT Executive no later than four (4) months prior to the Congress at which the Award will be presented. In order to avoid a conflict of interest, the Awards Committee must not communicate with the IATDMCT Executive or Council on their selection prior to making their final decision. However, the final Awards Committee decision requires the approval of the IATDMCT Executive.
Members of IATDMCT may propose suitable candidates to the Awards Committee through the Business Office of the association.
Nominations from the membership must be accompanied by a curriculum vitae including a list of publications, and a letter from the nominator containing an evaluation and appraisal of the nominee for the award. Additional letters of support by members of the Association or other respected scientists are helpful for the Selection Committee.
The presentation of the Award shall normally be at the Opening Ceremonies of the Congress of the association. The recipient of the Award is not usually expected to give an address or present a paper.
Sponsored by Siemens Healthcare Diagnostics
IATDMCT members are invited to nominate individuals for the IATDMCT awards. The award presentations will take place at the Opening Ceremonies of the bi-ennial Internation Congress of the IATDMCT.
How to Nominate: Nominations from members must be accompanied by curriculum vitae including a list of publications and a letter of support from the nominator containing an evaluation and appraisal of the nominee for the award. Additional letters of support from members of the Association or other respected scientists are welcomed as supporting information for the Selection Committee.
Deadline: March 31, 2015
Nominations must be received by March 31 of the Congress year.
Sander Vinks, Chair
Call for Nominations: Victor Armstrong Young Investigator Award
Presented to a Young Investigator for Exceptional Scientific Achievements Early in his/her Career.
This award is presented in honor of Dr. Victor Armstrong, International Association of Therapeutic Drug Monitoring and Clinical Toxicology Member, who passed away February 27, 2010.
Formerly the Young Investigator Award, at the May 27, 2010 meeting of the IATDMCT Executive this award was renamed the Victor Armstrong Young Investigator Award in honor of Dr. Victor Armstrong who passed away February 27, 2010.
The Award recognizes and encourages the professional development and achievements of a young investigator who has demonstrated exceptional scientific achievements early in his/her career.
The recipient must be a member in good standing of the Association on the day of the award presentation.
She/he must be 40 years of age or younger on the date specified as the deadline for receipt of nominations.
The Award shall be accompanied by a framed certificate and an honorarium in the amount of USD 1,000.
The recipient of the Award shall be chosen by the Awards Committee and approved by the IATDMCT Executive no later than four (4) months prior to the Congress at which the Award will be presented. In order to avoid a conflict of interest, the Awards Committee must no communicate with the IATDMCT Executive or Council on their selection prior to making their final decision. However, the final Awards Committee decision requires the approval of the IATDMCT Executive.
Nominations from the membership must be accompanied by a curriculum vitae including a list of publications, and a letter from the nominator containing an evaluation of the originality and importance of the candidate's contributions to therapeutic drug monitoring and/or clinical toxicology. Additional letters of support by members of the Association or other respected scientists are helpful for the Selection Committee.
Sponsored by Lippincott Williams & Wilkins
Association of University Radiologists Research & Education Foundation Ethics and Professionalism in Radiology Grant
To improve patient care, to improve patient safety, and to promote social responsibility in medical care and practice, by providing funding opportunities for the study and teaching of ethics and professionalism in radiology.
Nature of Projects
Applications that address any aspect of ethics and professionalism in radiology will be considered. Examples of types of projects include, but are not limited to the following:
Research of ethical dilemmas faced by academic radiologists or radiology physicians-in-training and the methods by which the dilemmas are addressed;
Educational program to teach ethics and professionalism to practicing radiologists, to radiology physicians-in-training, or to allied members of the academic radiology community.
In this program, up to $50,000 (USD) in aggregate may be awarded in a single year. This aggregate award may be to one or more individual applications.
The maximum individual award may not exceed $50,000 for a one year project.
The awards may be used for salary support and/or other project costs. Through this grant program, the AUR Research & Education Foundation does not pay institutional indirect costs or overhead costs, or tuition.
Unexpended funds must be returned to the Foundation.
Ethics and Professionalism in Radiology Project Grants begin in July. Grant payments will be made to the organizations of the grantees in semi-annual installments.
Deadline for Application
All applications must be created and submitted electronically as a MS Word or PDF file to the AUR R&E Foundation by January 10. If the deadline date falls on a weekend or holiday, the deadline will be extended to the next business day. Applications that are not complete, do not comply with the instructions, or do not have properly executed signatures, will not be reviewed.
Any member of the AUR is eligible to apply as principal investigator. It is not necessary for all members of the research or development team to be AUR members. Eligibility of the principal investigator must be maintained throughout the grant period.
Selection Criteria/Review Process
A study section consisting of physicians and scientists will review the application for merit and suitability. Final decisions will be subject to the approval of the AUR R & E Foundation Board of Directors. Applicants will be notified of the outcome of their applications by e-mail no later than May 15.
Stephanie Taylor, Account Executive
AUR R&E Foundation
820 Jorie Boulevard, Oak Brook, IL 60523